HACKENSACK, N.J. - A New Jersey judge presiding over the state's centralized NuvaRing blood clot litigation on April 18 granted summary judgment in all remaining cases in the first group of bellwether cases, finding that while the plaintiffs have stated a case questioning the adequacy of warnings, they failed to show that different warnings would have caused doctors not to prescribe the product or them not to use it (In Re: NuvaRing Litigation, No. BER-L-3081-09, N.J. Super., Bergen Co.)....(read more)![]()
↧